NFKB1 and coronary artery disorder: The NF-κB1 appears to be specifically involved in anti-inflammatory effects, and decreased NF-κB1 can promote the transcription of pro-inflammatory cytokines like TNF-α and IL-12 [40], which are contributors of CAD [41, 42].